Wetmore James B, Phadnis Milind A, Ellerbeck Edward F, Shireman Theresa I, Rigler Sally K, Mahnken Jonathan D
Department of Medicine, Division of Nephrology, Hennepin County Medical Center, Minneapolis, Minnesota; and
Department of Biostatistics.
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):80-9. doi: 10.2215/CJN.02900314. Epub 2014 Oct 15.
Stroke is common in patients undergoing long-term dialysis, but the implications for mortality after stroke in these patients are not fully understood.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A large cohort of dually-eligible (Medicare and Medicaid) patients initiating dialysis from 2000 to 2005 and surviving the first 90 days was constructed. Medicare claims were used to ascertain ischemic and hemorrhagic strokes occurring after 90-day survival. A semi-Markov model with additive hazard extension was generated to estimate the association between stroke and mortality, to calculate years of life lost after a stroke, and to determine whether race was associated with differential survival after stroke.
The cohort consisted of 69,371 individuals representing >112,000 person-years of follow-up. Mean age±SD was 60.8±15.5 years. There were 21.1 (99% confidence interval [99% CI], 20.0 to 22.3) ischemic strokes and 4.7 (99% CI, 4.2 to 5.3) hemorrhagic strokes after cohort entry per 1000 patient-years. At 30 days, mortality was 17.9% for ischemic stroke and 53.4% for hemorrhagic stroke. The adjusted hazard ratio (AHR) depended on time since entry into the cohort; for patients who experienced a stroke at 1 year after cohort entry, for example, the AHR of hemorrhagic stroke for mortality was 25.4 (99% CI, 22.4 to 28.4) at 1 week, 9.9 (99% CI, 8.4 to 11.6) at 3 months, 5.9 (99% CI, 5.0 to 7.0) at 6 months, and 1.8 (99% CI, 1.5 to 2.1) at 24 months. The corresponding AHRs for ischemic stroke were 11.7 (99% CI, 10.2 to 13.1) at 1 week, 6.6 (99% CI, 6.4 to 6.7) at 3 months, and 4.7 (99% CI, 4.5 to 4.9) at 6 months, remaining significantly >1.0 even at 48 months. Median months of life lost were 40.7 for hemorrhagic stroke and 34.6 for ischemic stroke. For both stroke types, mortality did not differ by race.
Dialysis recipients have high mortality after a stroke with corresponding decrements in remaining years of life. Poststroke mortality does not differ by race.
中风在长期透析患者中很常见,但这些患者中风后对死亡率的影响尚未完全明确。
设计、研究地点、参与者及测量指标:构建了一个大型队列,纳入2000年至2005年开始透析且存活90天以上的双重资格(医疗保险和医疗补助)患者。利用医疗保险理赔数据确定90天存活期后发生的缺血性和出血性中风。生成了一个具有相加风险扩展的半马尔可夫模型,以估计中风与死亡率之间的关联,计算中风后失去的生命年数,并确定种族是否与中风后的生存差异相关。
该队列由69371名个体组成,随访时间超过112000人年。平均年龄±标准差为60.8±15.5岁。队列进入后每1000患者年有21.1例(99%置信区间[99%CI],20.0至22.3)缺血性中风和4.7例(99%CI,4.2至5.3)出血性中风。在30天时缺血性中风死亡率为17.9%,出血性中风死亡率为53.4%。调整后的风险比(AHR)取决于进入队列后的时间;例如,对于队列进入后1年发生中风的患者,出血性中风死亡的AHR在1周时为25.4(99%CI,22.4至28.4),3个月时为9.9(99%CI,8.4至11.6),6个月时为5.9(99%CI,5.0至7.0),24个月时为1.8(99%CI,1.5至2.1)。缺血性中风相应的AHR在1周时为11.7(99%CI,10.2至13.1),3个月时为6.6(99%CI,6.4至6.7),6个月时为4.7(99%CI,4.5至4.9),即使在48个月时仍显著>1.0。出血性中风失去生命的中位数月数为40.7,缺血性中风为34.6。对于两种中风类型,死亡率在种族上无差异。
透析患者中风后的死亡率很高,剩余生命年数相应减少。中风后的死亡率在种族上无差异。